Clinical Outcomes After Revision Hip Arthroplasty due to Prosthetic Joint InfectiondA Single-Center Study of 369 Hips at a High-Volume Center With a Minimum of One Year Follow-Up

被引:4
作者
Liukkonen, Rasmus [1 ]
Honkanen, Meeri [2 ]
Skytta, Eerik [1 ]
Eskelinen, Antti [1 ]
Karppelin, Matti [2 ]
Reito, Aleksi [1 ]
机构
[1] Tampere Univ, Coxa Hosp Joint Replacement, Fac Med & Hlth Technol, Niveltie 4, Tampere 33520, Finland
[2] Tampere Univ Hosp, Dept Internal Med, Tampere, Finland
关键词
arthroplasty; hip; revision; infection; PJI; ONE-STAGE REVISION; IMPLANT RETENTION; CONTROL RATES; DEBRIDEMENT; ANTIBIOTICS; DURATION; RISK;
D O I
10.1016/j.arth.2023.08.078
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: Prosthetic joint infection (PJI) treatment decisions are traditionally based on treatment algorithms. There is, however, a lack of evidence to support the choice of these treatment algorithms. Therefore, we aimed to assess the one-year survival after PJI revision and compared different surgical strategies in a single -center setting. Methods: Revisions of the hip due to PJI performed at our institution between January 2008 and September 2021 with at least one-year of follow-up were identified. In total, 134 debridement, antibiotics, and implant retentions (DAIRs), 114 one -stage revisions, and 121 two -stage revisions were performed. Infections were classified as early, acute hematogenous, and chronic. Survival was calculated using the Kaplan -Meier method and cumulative incidence function. Predictors of outcomes were examined with Fine -Gray regressions and Cox proportional hazards regressions. Subdistribution hazard ratios and hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated. Results: At one-year follow-up, 26.6% (CI 22.2 to 31.2%) of the patients had undergone reoperation and 7.9% (CI 5.4 to 10.9%) had died. The risk for reoperation was highest after DAIR (36.6%, CI 28.5 to 44.7%) and lowest after one -stage revision (20.2%, CI 13.4 to 28%). Within the early infections, the one -stage revision almost halved the risk of reoperation (HR 0.51, CI 0.31 to 0.84) with no added mortality risk (HR 1.05, CI 0.5 to 2.2), when compared to DAIR. Conclusion: By utilizing 1 -stage revision over DAIR in early infections, it might be possible to improve the prognosis by decreasing the risk of reoperation without increasing mortality. However, as the patient selection is undeniably difficult, more research is warranted. (c) 2023 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页码:806 / 812.e3
页数:10
相关论文
共 21 条
  • [21] Acute promyelocytic leukemia: Epidemiology, clinical presentation, and outcome over a 10-year period of follow-up at Nanakali Hospital of Erbil city "Single-center study"
    Ahmed, Araz Taha
    Yassin, Ahmed Khudair
    Mohammed, Nawsherwan Sadiq
    Hasan, Kawa Muhamedamin
    IRAQI JOURNAL OF HEMATOLOGY, 2019, 8 (01) : 7 - 13